Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda.
Baraka V, Mavoko HM, Nabasumba C, Francis F, Lutumba P, Alifrangis M, Van Geertruyden JP. Baraka V, et al. Among authors: nabasumba c. PLoS One. 2018 Feb 1;13(2):e0191922. doi: 10.1371/journal.pone.0191922. eCollection 2018. PLoS One. 2018. PMID: 29390014 Free PMC article. Clinical Trial.
Impact of retreatment with an artemisinin-based combination on malaria incidence and its potential selection of resistant strains: study protocol for a randomized controlled clinical trial.
Muhindo Mavoko H, Nabasumba C, Tinto H, D'Alessandro U, Grobusch MP, Lutumba P, Van Geertruyden JP. Muhindo Mavoko H, et al. Among authors: nabasumba c. Trials. 2013 Sep 23;14:307. doi: 10.1186/1745-6215-14-307. Trials. 2013. PMID: 24059911 Free PMC article. Clinical Trial.
Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.
Mavoko HM, Nabasumba C, da Luz RI, Tinto H, D'Alessandro U, Kambugu A, Baraka V, Rosanas-Urgell A, Lutumba P, Van Geertruyden JP. Mavoko HM, et al. Among authors: nabasumba c. Lancet Glob Health. 2017 Jan;5(1):e60-e68. doi: 10.1016/S2214-109X(16)30236-4. Epub 2016 Nov 11. Lancet Glob Health. 2017. PMID: 27840069 Free article. Clinical Trial.
Different origin and dispersal of sulfadoxine-resistant Plasmodium falciparum haplotypes between Eastern Africa and Democratic Republic of Congo.
Baraka V, Delgado-Ratto C, Nag S, Ishengoma DS, Madebe RA, Mavoko HM, Nabasumba C, Lutumba P, Alifrangis M, Van Geertruyden JP. Baraka V, et al. Among authors: nabasumba c. Int J Antimicrob Agents. 2017 Apr;49(4):456-464. doi: 10.1016/j.ijantimicag.2016.12.007. Epub 2017 Feb 22. Int J Antimicrob Agents. 2017. PMID: 28237831
Glucose-6-phosphate dehydrogenase deficiency, chlorproguanil-dapsone with artesunate and post-treatment haemolysis in African children treated for uncomplicated malaria.
Van Malderen C, Van Geertruyden JP, Machevo S, González R, Bassat Q, Talisuna A, Yeka A, Nabasumba C, Piola P, Daniel A, Turyakira E, Forret P, Van Overmeir C, van Loen H, Robert A, D' Alessandro U. Van Malderen C, et al. Among authors: nabasumba c. Malar J. 2012 Jul 10;11:139. doi: 10.1186/1475-2875-11-139. Malar J. 2012. PMID: 22546009 Free PMC article. Clinical Trial.
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
Piola P, Nabasumba C, Turyakira E, Dhorda M, Lindegardh N, Nyehangane D, Snounou G, Ashley EA, McGready R, Nosten F, Guerin PJ. Piola P, et al. Among authors: nabasumba c. Lancet Infect Dis. 2010 Nov;10(11):762-9. doi: 10.1016/S1473-3099(10)70202-4. Lancet Infect Dis. 2010. PMID: 20932805 Clinical Trial.
Dihydroartemisinin-piperaquine and artemether-lumefantrine for treating uncomplicated malaria in African children: a randomised, non-inferiority trial.
Bassat Q, Mulenga M, Tinto H, Piola P, Borrmann S, Menéndez C, Nambozi M, Valéa I, Nabasumba C, Sasi P, Bacchieri A, Corsi M, Ubben D, Talisuna A, D'Alessandro U. Bassat Q, et al. Among authors: nabasumba c. PLoS One. 2009 Nov 17;4(11):e7871. doi: 10.1371/journal.pone.0007871. PLoS One. 2009. PMID: 19936217 Free PMC article. Clinical Trial.
Paediatric pharmacovigilance: use of pharmacovigilance data mining algorithms for signal detection in a safety dataset of a paediatric clinical study conducted in seven African countries.
Kajungu DK, Erhart A, Talisuna AO, Bassat Q, Karema C, Nabasumba C, Nambozi M, Tinto H, Kremsner P, Meremikwu M, D'Alessandro U, Speybroeck N. Kajungu DK, et al. Among authors: nabasumba c. PLoS One. 2014 May 1;9(5):e96388. doi: 10.1371/journal.pone.0096388. eCollection 2014. PLoS One. 2014. PMID: 24787710 Free PMC article.
25 results